Clinical Trial Update: Defined Green Tea Catechin Extract in Preventing Liver Cancer in Participants With Cirrhosis [Phase 1]

View source ↗

Summary

Phase 1 trial evaluating defined green tea catechin extract to prevent liver cancer in people with cirrhosis; the study is currently active but not recruiting.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Cirrhosis
• Hepatocellular Carcinoma

Drugs mentioned

• Defined Green Tea Catechin Extract (epigallocatechin gallate (EGCG))

Snippet

Sponsor: National Cancer Institute (NCI) | Conditions: Cirrhosis | Phase 1 | Status: ACTIVE_NOT_RECRUITING